Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 181

Results For "NABL"

2641 News Found

Ensure time-bound Infrastructure development of Ayush National Institutes/Central Councils projects: Sonowal
Policy | August 03, 2022

Ensure time-bound Infrastructure development of Ayush National Institutes/Central Councils projects: Sonowal

Ministry of Ayush has fast tracked up-gradation and construction of various Ayush Infrastructure across the country


PIB: India imported Rs. 35,249 crore worth APIs and Bulk drugs in 2021-22.
Policy | August 03, 2022

PIB: India imported Rs. 35,249 crore worth APIs and Bulk drugs in 2021-22.

India exported Bulk Drugs/Drug Intermediates worth Rs. 33,320 crore in financial year 2021-22.


BioIVT promotes Dr. Richard Haigh to CEO
People | August 02, 2022

BioIVT promotes Dr. Richard Haigh to CEO


Shilpa Medicare's Unit III, Advanced Analytical Characterization Laboratory clears US FDA remote record review
Drug Approval | July 31, 2022

Shilpa Medicare's Unit III, Advanced Analytical Characterization Laboratory clears US FDA remote record review

The facility is designed with advanced analytical equipment to provide testing services such as In-vitro Permeation testing


Cariflex breaks ground on world's largest polyisoprene latex plant in Singapore
News | July 29, 2022

Cariflex breaks ground on world's largest polyisoprene latex plant in Singapore

Driven by a strong commitment to better serve its global customers in medical and consumer products, this investment represents the largest capacity expansion in Cariflex’s existing accomplishments


Pharmaceuticals industry under Atmanirbhar Bharat programme
Policy | July 27, 2022

Pharmaceuticals industry under Atmanirbhar Bharat programme

India exported about Rs 33,321 crore and imported Rs 35,249 crore worth APIs and Bulk drugs in 2021-22.


Ascentage Pharma and Tanner Pharma Group initiate a global innovative named Patient Program
News | July 27, 2022

Ascentage Pharma and Tanner Pharma Group initiate a global innovative named Patient Program

Tanner will be the supplier of olverembatinib to healthcare providers on a named patient basis in countries where the drug is not commercially available.


AstraZeneca collaborates with – Indian Society of Nephrology to launch CKD Academy
News | July 27, 2022

AstraZeneca collaborates with – Indian Society of Nephrology to launch CKD Academy

AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.


Sun Pharma and Cosmo announce territory expansion of license and supply agreements for WINLEVI
Supply Chain | July 26, 2022

Sun Pharma and Cosmo announce territory expansion of license and supply agreements for WINLEVI

Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.